Trials / Completed
CompletedNCT06230679
Effectiveness of NESA in the Treatment of Cancer Survivors
Effectiveness of NESA in the Treatment of Sleep Problems, Fatigue, and Neuromuscular Pain in Cancer Survivors.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Aníbal Báez Suárez · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Cancer is a disease, or a set of diseases, that increased in our society. However, improvements in their detection and treatment increase the number of patients who survive. Every year 2.6 million people are diagnosed in the European Union and 1.4 million become cancer survivors. However, these people suffer the late adverse effects of treatment that can seriously affect their quality of life. the most common late effects are pain, fatigue, and sleeping difficulties. These are estimated between 58-90%. The autonomic nervous system (ANS) appears to play an important role in the manifestation and perpetuation of these symptoms.
Detailed description
This study aims to evaluate NESA (or NESA non-invasive neuromodulation) to treat the most common long-term side effects in cancer survivors, due to the most used treatments. It will be compared between two groups of cancer survivors. The intervention group, with electrical stimulation, and the sham group, without electrical stimulation emission. The subjects will be assigned randomly. Neither the patient, the therapist, nor the analysts/researchers will know the assignment. Finally, this project aims to add a passive tool to the therapeutic arsenal of health professionals in the oncology field for the treatment of late side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Non-invasive Neuromodulation | Patients receive non-invasive neurostimulation through the Nesa device |
| DEVICE | Placebo Non-invasive Neuromodulation | The same protocol described for the experimental group will be applied, but electrical stimulation device which will be previously manipulated and tested with an oscilloscope so that they do not emit electrical currents. |
Timeline
- Start date
- 2024-01-19
- Primary completion
- 2025-09-19
- Completion
- 2025-12-19
- First posted
- 2024-01-30
- Last updated
- 2026-01-16
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06230679. Inclusion in this directory is not an endorsement.